1 |
朱燕亭,宋旸,李少军,等. 哮喘与慢性阻塞性肺疾病重叠综合征的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(3): 377-379.
|
2 |
李超,方圆,李志奎. 哮喘-COPD重叠综合症相关性疾病166例分析[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(6): 704-709.
|
3 |
颜文杰,宋勇. 哮喘-慢性阻塞性肺疾病重叠综合征研究的进展[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(3): 356-357.
|
4 |
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease ( Updated 2014 ) .
URL
|
5 |
Global strategy for asthma management and prevention 2014(revision).
URL
|
6 |
Global Strategy for the Diagnosis, Management and Prevention of COPD,Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015
URL
|
7 |
Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2017. Vancouver, USA GINA; 2017.
|
8 |
Menezes AMB, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype:COPDAsthma[J]. Chest, 2014, 145(2): 297-304.
|
9 |
Postma DS, Rabe KF. The Asthma-COPD Overlap Syndrome[J]. N Engl J Med, 2015, 373(13): 1241-1249.
|
10 |
Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD:what are its features and how important is it? [J]. Thorax, 2009, 64(8): 728-735.
|
11 |
Hakonarson H, Carter C, Kim C, et al. Altered expression and action of the low-affinity IgE receptor FcepsilonRII (CD23) in asthmatic airway smooth muscle[J]. J Allergy Clin Immunol, 1999, 104(1): 575-584.
|
12 |
Postma DS, Rabe KF. The asthma-COPD overlap syndrome[J]. N Engl J Med, 2015, 373(13): 1241-1249.
|
13 |
Gelb AF, Yamamoto A, Verbeken EK, et al. Unraveling the pathophysiology of the asthma-COPD overlap syndrome: un-suspected mild centrilobular emphysema Is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation[J]. Chest, 2015, 148(2): 313-320.
|
14 |
Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2015, 191(7): 758-766.
|
15 |
Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome[J]. Eur Respir J, 2014, 44(2): 341-350.
|
16 |
Smolonska J, Koppelman GH, Wijmenga C, et al. Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis[J]. Eur Respir J, 2014, 44(4): 860-872.
|
17 |
McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease[J]. N Engl J Med, 2011, 365(17): 1567-1575.
|
18 |
Sunil VR, Patel KJ, Mainelis G, et al. Pulmonary effects of inhaled diesel exhaust in aged mice[J]. Toxicol Appl Pharmacol, 2009, 241(3): 283-293.
|
19 |
Erzurum SC. New Insights in Oxidant Biology in Asthma[J]. Ann Am Thorac Soc, 2016, 13(Suppl 1): S35-S39.
|
20 |
Kalinina EP, Denisenko YK, Vitkina TI, et al. The Mechanisms of the Regulation of Immune Response in Patients with Comorbidity of Chronic Obstructive Pulmonary Disease and Asthma[J]. Can Respir J, 2016, 2016(6): 1-8.
|
21 |
Kobayashi S, Hanagama M, Yamanda S, et al. Inflammatory biomarkers in asthma-COPD overlap syndrome[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 2117-2123.
|
22 |
Brzostek D, Kokot M. Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study [J]. Postepy Dermatol Alergol, 2014, 31(6): 372-379.
|
23 |
Chung WS, Lin CL, Kao CH. Comparison of Acute Respiratory Events between Asthma-COPD Overlap Syndrome and COPD Patients: A Population-Based Cohort Study[J]. Medicine (Baltimore), 2015, 94(17): e755.
|
24 |
Yeh JJ, Wang YC, Kao CH. Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism[J]. PLoS One, 2016, 11(9): e0162483.
|
25 |
Yeh JJ, Wang YC, Kao CH. Asthma-Chronic Obstructive Pulmonary Diseases Overlap Syndrome Increases the Risk of Incident Tuberculosis: A National Cohort Study[J]. Plos One, 2016, 11(7): e0159012.
|
26 |
Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD[J]. Arch Bronconeumol, 2012, 48(9): 331-337.
|
27 |
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2016.
URL
|
28 |
Cheng SL, Lin CH. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11(1): 2341-2348.
|
29 |
Castiglia D, Battaglia S, Benfante A, et al. Pharmacological management of elderly patients with asthma-chronic obstructive pulmonary disease overlap syn-drome: room for speculation?[J]. Drugs Aging, 2016, 33(6):375-385.
|
30 |
Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial[J]. Ann Intern Med, 2009, 151(8): 517-527.
|
31 |
Antoniu SA. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease[J]. Expert Opin Ther Targets, 2014, 18(11): 1285-1292.
|
32 |
Nakawah MO, Hawkins C, Barbandi F. Asthma, Chronic Obstructive Pulmonary Disease (COPD), and the Overlap Syndrome[J]. J Am Board Fam Med, 2013, 26(4): 470-477.
|
33 |
Louie S, Zeki AA, Schivo M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations[J]. Expert Rev Clin Pharmacol, 2013, 6(2): 197-219.
|
34 |
Ding B, Enstone A. Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights[J]. Expert Rev Respir Med, 2016, 10(3): 363-371.
|
35 |
Segreti A, Stirpe E, Rogliani P, et al. Defining phenotypes in COPD: anaid to personalized healthcare[J]. Mol Diagn Ther, 2014, 18(4): 381-388.
|